FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Collagen Matrix Zcore Syringe Device Adulterated: FDA

[ Price : $8.95]

FDAs New Jersey District Office warns Collagen Matrix that its Zcore porcine xenograft particulate in syringe device is adulterate...

20th Patient-Focused Drug Development Meeting

[ Price : $8.95]

CDERs Theresa Mullin says FDA completed its commitment to hold 20 patient-focused drug development meetings one year early.

FDA: Nippon Fine Chemical Limited, Refused Inspection

[ Price : $8.95]

FDA warns Japans Nippon Fine Chemical Co. that its products are considered adulterated because the company limited and refused an ...

Benefits to Having Device Identifier on Forms: OIG

[ Price : $8.95]

The HHS Inspector General sees advantages for Medicare in including device identifiers on claim forms.

FDA Evaluating Need for Safety Signal Action

[ Price : $8.95]

FDA says it is evaluating safety signals on 22 drugs or groups of drugs received between April and June.

Tute Genomics DNA Project Closed after FDA Letter

[ Price : $8.95]

Tute Genomics says it is postponing a crowd-funded consumer genomics program after FDA questioned its marketing approach.

CDRH Working to Reduce Medical Device Misconnections

[ Price : $8.95]

CDRH says it is working with standards organizations, federal partners, professional societies, advocacy groups, patients and othe...

Microbiology Devices Panel to Meet 11/9-10

[ Price : $8.95]

Federal Register Notice: FDA annouces an 11/9-10 Microbiology Devices Panel of the Medical Devices Advisory Committee meeting in G...

Workshop on Semantic Interoperability of Lab Data

[ Price : $8.95]

Federal Register Notice: FDA and other government agencies host an 11/8 public workshop on Promoting Semantic Interoperability of ...

Jazz Begins Rolling NDA for Leukemia Drug Vyxeos

[ Price : $8.95]

Jazz Pharmaceuticals begins a rolling NDA submission for Vyxeos (cytarabine and daunorubicin liposome injection), an investigation...